E154
M. T. Maghsoodlou, N. Hazeri, K. Khandan-Barani, S. M. Habibi-Khorasani, and A. Abedi
Vol 51
an ionization potential of 70eV. Elemental analysis for C, H, and N
were performed by using a Heraeus CHN–O Rapid analyzer
(Germany).
1-(Cyclohexylamino)-2-(4-nitrophenyl)pyrrolo[1,2-a]
quinoline-3-carbonitrile (5d). Yellow powder, yield 0.36 g
(88%), mp 151–153ꢀC; IR (KBr) (nmax, cmÀ1): 3435 (NH),
1
General procedure for the synthesis of 1-(cyclohexylamino)-
2-(aryl)pyrrolo[1,2-a]quinoline-3-carbonitrile derivatives
(5a–e). The process for the preparation of 1-(cyclohexylamino)-
2-(2,5-dimethoxyphenyl)pyrrolo[1,2-a]quinoline-3-carbonitrile (5a)
is described as an example. The solution of cyclohexyl
isocyanide (0.11 g, 1 mmol) in 3 mL of CH2Cl2 solvent was
slowly added dropwise to a stirred solution of an equimolar
mixture of malononitrile (0.06 g, 1 mmol), quinoline (0.13 g,
1 mmol), and 2,5-dimethoxy benzaldehyde (0.17 g, 1 mmol)
in the presence of a catalytic amount of titanium dioxide (TiO2)
in CH2Cl2. The reaction mixture is stirred for 12 h at
room temperature. The solvent was removed under reduced
pressure, and the residue was purified by silica gel column
chromatography with the used of petroleum ether–ethylacetate
(90:10).
2209 (CN); H NMR (250.1 MHz, CDCl3): d 0.82–1.74 (10H,
m, 5CH2), 2.72–2.80 (1H, m, NCH), 7.26–7.76 (9H, m, NH
and CHarom), 8.38 (1H, d, J = 8.50 Hz, CH), 9.42 (1H, d,
J = 8.50 Hz, CH); 13C NMR (62.9 MHz, CDCl3): d 24.7, 25.4,
33.1 (3s, 5CH2 of cyclohexyl), 56.9 (s, NCH of cyclohexyl),
83.5 (C(CN)), 116.3 (CN), 117.8, 124.3, 124.4, 125.1, 125.3,
128.1, 128.8, 129.7, 133.1, 134.4, 134.6, 139.6, 146.9; ms
(m/z, %): 410 (M+, 9), 327 (25), 280 (20), 167 (10), 150
(15), 83 (48), 77 (20), 55 (100). Anal. Calcd for C25H22N4O2
(410.47): C, 73.15; H, 5.40; N, 13.65%. Found: C, 73.21; H,
5.49; N, 13.72%.
1-(Cyclohexylamino)-2-(3-chlorophenyl)pyrrolo[1,2-a]
quinoline-3-carbonitrile (5e).
Yellow powder; yield 0.36 g
(90%), mp 100–102ꢀC; IR (KBr) (nmax, cmÀ1): 3340 (NH), 2209
(CN); 1H NMR (250.1 MHz, CDCl3): d 0.63–1.73 (10H, m,
5CH2 of cyclohexyl), 2.65–2.87 (1H, m, NCH of cyclohexyl),
7.26–7.73 (9H, m, NH and CHarom), 8.10 (1H, d, J = 8.50Hz,
CH), 9.44 (1H, d, J = 8.50 Hz, CH); 13C NMR (62.9MHz,
CDCl3): d 24.5, 25.5, 34.1 (3s, 5CH2 of cyclohexyl), 53.3
(s, NCH of cyclohexyl), 87.7 (C(CN)), 116.4 (CN), 118.8,
124.6, 124.8, 125.3, 125.5, 127.4, 128.8, 129.0, 133.3, 134.8,
135.0, 138.5, 147.6; ms (m/z, %): 401 (M++2, 23), 399 (M+, 64),
364 (3), 316 (100), 289 (20), 281 (45), 128 (32), 55 (57). Anal.
Calcd for C25H22ClN3 (399.92): C, 75.08; H, 5.54; N, 10.51%.
Found: C, 75.29; H, 5.62; N, 10.59%.
1-(Cyclohexylamino)-2-(2,5-dimethoxyphenyl)pyrrolo[1,2-
a]quinoline-3-carbonitrile (5a). Yellow powder, yield 0.34 g
(80%), mp 130–132ꢀC; IR (KBr) (nmax, cmÀ1): 3341 (NH),
1
2209 (CN); H NMR (250.1 MHz, CDCl3): d 0.99–1.74 (10H,
m, 5CH2 of cyclohexyl), 2.73 (1H, m, NCH), 3.84 and 3.86 (2s,
2OCH3), 6.92–7.71 (8H, m, NH and CHarom), 7.56 (1H, d,
J = 8.50 Hz, CH), 9.56 (1H, d, J = 8.50 Hz, CH); 13C NMR
(62.9 MHz, CDCl3):
d 24.8, 25.6, 33.1 (3s, 5CH2 of
cyclohexyl), 55.9 and 57.0 (2s, 2OCH3), 56.3 (s, NCH of
cyclohexyl), 92.1 (C–CN), 113.6, 114.7, 116.5, 116.8, 118.1
(CN), 123.1, 124.5, 125.2, 127.7, 128.4, 134.9, 133.5, 150.5,
152.5, 154.2; ms (m/z, %): 425 (M+, 42), 342 (83), 311 (11),
223 (18) 165 (38), 129 (41), 77 (58), 55 (100). Anal. Calcd for
C27H27N3O2 (425.52): C, 76.21; H, 6.40; N, 9.87%. Found: C,
76.39; H, 6.49; N, 9.99%.
Acknowledgments. We gratefully acknowledge financial support
from the Research Council of University of Sistan and
Baluchestan.
1-(Cyclohexylamino)-2-(2,3-dimethoxyphenyl)pyrrolo[1,2-
a]quinoline-3-carbonitrile (5b).
Pale yellow powder, yield
0.33 g (78%), mp 138–140ꢀC; IR (KBr) (nmax, cmÀ1): 3325
REFERENCES AND NOTES
1
(NH), 2200 (CN); H NMR (250.1 MHz, CDCl3): d 0.83–1.84
(10H, m, 5CH2), 3.66–3.68 (1H, m, NCH), 3.81 and 3.82
(2s, 2OCH3), 6.73–7.75 (8H, m, NH and CHarom), 7.60 (1H, d,
J = 8.50 Hz, CH), 9.47 (1H, d, J = 8.50Hz, CH); 13C NMR
[1] Gerencser, J.; Dormon, G.; Darvas, F. QSAR Comb Sci 2006,
25, 439.
[2] Ramon, D. J.; Yus, M. Angew Chem Int Ed 2005, 44, 1602.
[3] Hulme, C.; Gore, V. Curr Med Chem 2003, 10, 51.
[4] Trost, B. M. Angew Chem Int Ed 1995, 34, 259.
[5] Bienayme, H.; Hulme, C.; Oddon, G.; Schmitt, P. Chem Eur J
2000, 6, 3321.
[6] Domling, A.; Ugi, I. Angew Chem Int Ed 2000, 39, 3168.
[7] Mohammed, I. A.; Subrahmanyam, E. V. S. Acta Pharm
Sciencia 2009, 51, 163.
(62.9 MHz, CDCl3):
d 24.3, 25.6, 34.7 (3s, 5CH2 of
cyclohexyl), 55.7 and 59.9 (2s, 2OCH3), 55.8 (s, NCH of
cyclohexyl), 93.0 (C(CN)), 112.0, 114.8, 115.9, 116.4, 119.7
(CN), 121.1, 122.9, 126.0, 127.8, 128.6, 129.4, 130.1, 133.8,
137.1, 151.4, 153.5; ms (m/z, %): 425 (M+, 12), 342 (25),
311 (3), 145 (32), 129 (100), 77 (38). Anal. Calcd for
C27H27N3O2 (425.52): C, 76.29; H, 6.48; N, 9.94%. Found:
C, 76.42; H, 6.40; N, 9.87%.
[8] Pellerano, C.; Savini, L.; Massarelli, P.; Bruni, G.; Fiaschi,
A. I. Farmacol 1990, 45, 269.
[9] Fournet, A.; Barrios, A. A.; Munoz, V.; Hocquemiller, R.;
Cave, A.; Bruneton, J. Am Soc Microbiol 1993, 31, 859.
[10] Upadhayaya, R. S.; Vandavasi, J. K.; Vasireddy, N. R.;
Sharma, V.; Dixit, S. S.; Chattopadhyaya, J. Bioorg Med Chem 2009,
17, 2830.
[11] Balasubramanian, M.; Kay, J. G. In Comprehensive Heterocyclic
Chemistry; Katrizky, A. R.; Rees, C. W.; Scriven, E. F. V., Ed.; Pergamon:
London, 1996; Vol. 5, Chapter 5.05. pp 245–300.
[12] Vlahov, R.; Parushev, S.; Vlahov, J. Pure Appl Chem 1990,
62, 1303.
[13] Lamazzi, C.; Leonce, S.; Pfeiffer, B.; Renard, P.; Guillaumet,
G.; Reese, C. W.; Besson, T. Bioorgan Med Chem Lett 2000, 10, 2183.
[14] Luo, Z.; Zeng, C.; Wang, F.; He, H.; Wang, C.; Du, H.; Hu, L.
Chem Res Chinese Univ 2009, 25, 841.
1-(Cyclohexylamino)-2-(4-fluorophenyl)pyrrolo[1,2-a]
quinoline-3-carbonitrile (5c).
Pale yellow powder; yield
0.34 g (90%), mp 142–144ꢀC; IR (KBr) (nmax, cmÀ1): 3357
(NH), 2211 (CN); 1H NMR (250.1 MHz, CDCl3): d 1.02–1.77
(10H, m, 5CH2), 2.76–3.10 (1H, m, NCH), 7.17–7.71(9H, m,
NH and CHarom), 7.73 (1H, d, J = 8.50 Hz, CH), 9.51(1H, d,
J = 8.50 Hz, CH); 13C NMR (62.9 MHz, CDCl3): 24.5, 24.8,
25.5, 32.9, 33.2 (5s, 5CH2 of cyclohexyl), 56.5 (s, NCH of
cyclohexyl), 84.6 (C(CN)), 116.4 (CN), 117.9, 118.8, 123.3,
124.8, 125.3, 127.7, 128.6, 129.8, 130.1, 133.3, 133.9, 134.7,
134.8; ms (m/z, %): 384 (M++1, 5), 280 (20), 268 (7), 129
(100), 102 (93), 84 (70), 55 (67). Anal. Calcd for C25H22FN3
(383.46): C, 78.30; H, 5.78; N, 10.96%. Found: C, 78.51; H,
5.86; N, 11.08%.
[15] Bonnett, R.; North, S. A. Adv Heterocycl Chem 1981, 29, 341.
[16] Hadden, M.; Stevenson, P. J. Tetrahedron Lett 1999, 40, 1215.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet